For the first time, CLL Society has published a press release reflecting on our significant achievements for the chronic lymphocytic leukemia and small lymphocytic lymphoma (CLL/SLL) community this past year. In 2022, CLL Society took major steps forward in expanding our four pillars: education, support, advocacy, and research.
The official launch of our Research Program and announcement of our first Young Investigator Award research grant was a vital effort in CLL Society becoming an organization committed to and actively working towards a cure for CLL/SLL. CLL Society is also incredibly proud of how our advocacy and policy efforts have taken shape and led to changing the definition of ‘immunocompromised’ to make life-saving COVID-19 therapeutics more readily available to members of our vulnerable community. Furthermore, our support groups grew over the year, Facebook live events were added to our webinar program, and a new website was launched to make critical education and support easier to find.
None of this would have been possible without our dedicated supporters, who we are incredibly grateful to have at our side. We are thrilled to share this news with the broader public to increase awareness of the needs of those living with CLL/SLL and the services we provide for this community. CLL Society is well-poised to continue growing and reach more individuals who CLL/SLL impacts. 2023 is off to a great start, and we cannot wait to see what we do together this year.
Read CLL Society’s Press Release: CLL Society Increases Its Reach, Funds Critical Cancer Research and Advocates for the Immunocompromised in 2022; Starts New Year Poised for Further Growth